RayzeBio to Participate in Upcoming Investor Conferences in November 2023

Grand News Network | November 6, 2023

SAN DIEGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (NASDAQ:RYZB), a biopharmaceutical company developing an innovative radiopharmaceutical pipeline to treat different cancers, today announced that members of the Company's management team will participate in the following investor conferences in November 2023:

  • Truist Securities BioPharma Symposium: Panel discussion on Wednesday, November 8 at 10:45 a.m. ET in New York.
  • Jefferies London Healthcare Conference: ...

Full story available on Benzinga.com

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner

Copyright © 2024 | All rights reserved